Earnings release
Page 1
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . +3 石 四 藥 集團 有限公司 SSY Group Limited ( Incorporated in the Cayman Islands with limited liability ) ( Stock Code : 2005 ) ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 CHAIRMAN'S STATEMENT On behalf of the board of directors ( the “ Board ” ) of SSY Group Limited ( the “ Company ” ) , I hereby present the unaudited interim results of the Company and its subsidiaries ( together , the “ Group ” ) for the six months ended 30 June 2021 . I. RESULT AND DIVIDEND DISTRIBUTION During the first half of 2021 , amidst the normality under novel coronavirus epidemic domestically and internationally and despite the severe challenges brought by the unexpected outbreak of the epidemic in Shijiazhuang in early 2021 , the Group managed to cope well with unfavorable factors arising from the epidemic with its endeavor in production and implementation of various measures to ensure market support , and thus achieved the stable development of the Group . During the period , the Group continued to promote its business strategy of scientific research , innovation and structural optimization , actively responded to the national and local centralized procurement policies and the new situation of economic changes under the epidemic normality , as well as increased its effort in promoting the formation of the operation pattern of integrated and collaborative development in relation to the whole industry chain and diversified dosage forms from medical materials , bulk pharmaceuticals to high - end preparations . New products and product types under evaluations have been approved successively , providing new momentum for the continuously stable and favourable market development of the Group . 1